MyDx Inc. (fka MYDX)

[DarthYoda]

Eh? You guys should know better than me, he only worked at Pfizer for 3 years in the early 2000s. He worked at Panasonic after Pfizer, and for a much longer 9 years. IMO Daniel was part of an initially well-intentioned group from the broader cannabis industry that aimed to do something cool in the cannabis space, but as is often the case with public startup companies, the financing became the business. Maybe Daniel always intended to screw everyone else over, but I don't think that became the sole intention until after it became publicly traded.

https://www.indiegogo.com/projects/mydx#/

The unethical, yet apparently legal, 3a exemption method of dumping shares before Rule 144's 6months was the cherry on top with this one. I don't think Daniel was the tippy top of the scam though by the end. Did the DD and Fraud board never come up with any other candidates? What about the financiers? Wasn't there some guy named Mr. Panther, and I think his wife? Anyway...

https://www.linkedin.com/in/daniel-r-yazbeck-m-sc-2850069

Publications
(Main Contributor is First Author)

Daniel Yazbeck; Martinez, C.A. ; Hu, S.; Tao, J. Challenges in the Development of an Efficient Enzymatic Process in the Pharmaceutical Industry. Tetrahedron Asymmetry, 2004, 15, 2757-2763.
Daniel Yazbeck; Tao, J.; Martinez, C. A.; Kline, B. J.; Hu, S. Automated Enzyme Screening Methods for the Preparation of Enantiopure Pharmaceutical Intermediates. Adv. Synth. Catal . 2003 , 345 , 524-532.
Daniel Yazbeck ; Durao, P. J.; Xie, Z.; Tao, J. A High Throughput Metal Ion Based Methods for Nitrilase Screening, J. Mol. Cat. B , 2006, 39, 156-159 (special issue).
Daniel Yazbeck ; Derrick, A.; Panesar, M.; Deese, A.; Gujral, A.; Tao, J. Enzymatic Hydrolysis of Racemic and Cis/Trans Ethyl Bicyclo[3.2.0]hept-6-ylidene-acetate: Solvent Effect and NMR Study, Org. Process. Res. Dev. , 2006 , 10 (3), 655 -660.
Rossi, F., Daniel Yazbeck, et. al. Process Research and Development and Scale-up of a 4,4-Difluoro-3,3-dimethylproline Derivative. Org. Process. Res. Dev., 2008, 12, 322–338
Xie, J.; Feng, J.; Garcia, E.; Bernett, M.; Daniel Yazbeck ; Tao, J. Cloning and Optimization of a Nitrilase for the Synthesis of (3S)-3-Cyano-5-methyl Hexanoic Acid, J. Mol. Cat. B, 2006.
Hu, S.; Martinez , C.; Kline,B.; Daniel Yazbeck ; Tao, J. Efficient and Scalable Enzymatic Process for the Production of (2S)-4,4-Difluoro-3,3-dimethyl-N-Boc-proline, a Key Intermediate in the Synthesis of HIV Protease Inhibitors, Org. Process. Res. Dev., 2006, ASAP 2006:239222 (special issue).
Lijian Chen, Young Mi Kim, David J. Kucera, Katheryn E. Harrison, Sogole Bahmanyar, Jill M. Scott, and Daniel Yazbeck. Fluorination-Free Synthesis of a 4,4-Difluoro-3,3-Dimethylproline Derivative. J. Org. Chem. 2006, 5 (3) .
Hu, S., Tat, D., Martinez , C., Daniel Yazbeck , Tao, J. An Efficient and Practical Chemoenzymatic Preparation of Optically Active Secondary Amines. Organic Letters, 2005 , 7 , 4329-4331.
Martinez , C.A. , Daniel Yazbeck , Tao, J. An Efficient Enzymatic Preparation of Rhinovirus Protease Inhibitor Intermediates. Tetrahedron. 2003 , 60 , 759-764.
Daniel Yazbeck , Damha M.J. Molecular Requirements for degradation of a modified sense RNA strand by Escherichia coli Ribonuclease H1. Nucleic Acid Research. 2002, 30, 3015-2025.
Daniel Yazbeck. Molecular Requirements for Degradation of RNA in DNA/RNA Hybrids by RNase H. MSc. Thesis, McGill University, Montreal, Canada, 2001.
Daniel Yazbeck; Derrick, A.M. Resolution of racemic cis/trans ( 1R,5R)-Ethyl bicyclo[3.2.0]hept-6-ylideneacetate using Candida Antartica Lipase B. Industrial Biotransformations, Wiley-VCH, 2nd edition, 2005.

Patents
(Authorship in Alphabetical Order)

Hu, S., Martinez, C., Tao, J., Yazbeck, Daniel. Methods for the Preparation of Stereoisomerically Enriched Amines. 2005 . WO 2005/054186 (world patent).
Hu, S., Martinez, C., Tao, J., Yazbeck, Daniel. Efficient Microbial Preparation of Capravirine Metabolites M4 and M5. 2005 . US 2005/0043361A1.
Matthews, C., Mitchell, M., Scott, R., Yazbeck, Daniel. Method For the Preparation of HCV Polymerase Inhibitors, 2004 , PC32421 PROV.
Derrick, A., Yazbeck, Daniel. Intermediates In The Preparation of Therapeutic Fused Bicyclic Amino Acids, 2003 , PC025386PGS (U.S. Application Serial No.: 10/677,83)
Chen, L, Borer, B., Kline, B., Lee, S. Michell, M., Martinez, C., Sakata, S., O’Neill-Slawecki, S., Tao, Junhua, Yazbeck, Daniel. Preparation of AG7404 Chiral Intermediates. 2003, PC25397.
Hu, Shanghui, Martinez , C., Tao, J., Tat, D., Yazbeck, Daniel. An Efficient Preparation of Enatiopure Secondary Amines by a Protease Catalyzed Kinetic Resolution. 2003, PC25652.

https://yazbeckinvestments.com/references/